Alzamend Neuro, Inc. (ALZN)
1.13
+0.01
(+0.89%)
USD |
NASDAQ |
Oct 23, 16:00
1.13
0.00 (0.00%)
After-Hours: 20:00
Alzamend Neuro Market Cap : 5.453M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 5.453M |
| October 22, 2026 | 5.405M |
| October 21, 2026 | 6.032M |
| October 20, 2026 | 6.273M |
| October 19, 2026 | 6.418M |
| October 16, 2026 | 6.273M |
| October 15, 2026 | 6.177M |
| October 14, 2026 | 6.515M |
| October 13, 2026 | 6.515M |
| October 12, 2026 | 6.322M |
| October 09, 2026 | 6.466M |
| October 08, 2026 | 6.466M |
| October 07, 2026 | 6.611M |
| October 06, 2026 | 6.611M |
| October 05, 2026 | 6.804M |
| October 02, 2026 | 6.611M |
| October 01, 2026 | 6.346M |
| September 30, 2026 | 8.348M |
| September 29, 2026 | 8.783M |
| September 28, 2026 | 8.348M |
| September 25, 2026 | 8.831M |
| September 24, 2026 | 8.783M |
| September 23, 2026 | 9.362M |
| September 22, 2026 | 9.362M |
| September 21, 2026 | 9.362M |
| Date | Value |
|---|---|
| September 18, 2026 | 9.121M |
| September 17, 2026 | 8.879M |
| September 16, 2026 | 8.831M |
| September 15, 2026 | 8.590M |
| September 14, 2026 | 8.445M |
| September 11, 2026 | 8.300M |
| September 10, 2026 | 8.204M |
| September 09, 2026 | 8.107M |
| September 08, 2026 | 8.107M |
| September 04, 2026 | 7.065M |
| September 03, 2026 | 7.235M |
| September 02, 2026 | 7.235M |
| September 01, 2026 | 6.966M |
| August 31, 2026 | 6.810M |
| August 28, 2026 | 7.065M |
| August 27, 2026 | 7.086M |
| August 26, 2026 | 7.108M |
| August 25, 2026 | 6.810M |
| August 24, 2026 | 6.597M |
| August 21, 2026 | 6.639M |
| August 20, 2026 | 6.937M |
| August 19, 2026 | 6.469M |
| August 18, 2026 | 6.469M |
| August 17, 2026 | 6.724M |
| August 14, 2026 | 6.597M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| Price to Book Value | 0.9397 |
| Price | 1.13 |
| Earnings Yield | -202.5% |